BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nakashima C, Shingo K, Fujiwara-Tani R, Luo Y, Kawahara I, Goto K, Sasaki T, Fujii K, Ohmori H, Kuniyasu H. Expression of long-chain fatty acid receptor GPR40 is associated with cancer progression in colorectal cancer: A retrospective study. Oncol Lett 2018;15:8641-6. [PMID: 29805599 DOI: 10.3892/ol.2018.8383] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Ungaro F, D'Alessio S, Danese S. The Role of Pro-Resolving Lipid Mediators in Colorectal Cancer-Associated Inflammation: Implications for Therapeutic Strategies. Cancers (Basel) 2020;12:E2060. [PMID: 32722560 DOI: 10.3390/cancers12082060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ogata R, Mori S, Ohmori H, Kishi S, Fujiwara-Tani R, Sasaki T, Nishiguchi Y, Nakashima C, Goto K, Kawahara I, Luo Y, Kuniyasu H. Suppressive GLI2 fragment enhances liver metastasis in colorectal cancer. Oncotarget 2022;13:122-35. [PMID: 35047127 DOI: 10.18632/oncotarget.28170] [Reference Citation Analysis]
3 Cosín-Roger J, Ortiz-Masia D, Barrachina MD, Calatayud S. Metabolite Sensing GPCRs: Promising Therapeutic Targets for Cancer Treatment? Cells 2020;9:E2345. [PMID: 33113952 DOI: 10.3390/cells9112345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Bartoszek A, Fichna J, Tarasiuk A, Binienda A, Fabisiak A, Krajewska JB, Mosińska P, Niewinna K, Salaga M. Free Fatty Acid Receptors as New Potential Targets in Colorectal Cancer. Curr Drug Targets 2020;21:1397-404. [PMID: 31721710 DOI: 10.2174/1389450120666191112141901] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]